onkoserv

Indikation: Endometriumkarzinom

zurück

2012

External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma: A Prospective, Randomized Study-Quality-of-Life Analysis

Int J Gynecol Cancer 22 (2012) Online first 2. 8. 2012

Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage

BMC Cancer 12 (2012) 128

Comparative Effectiveness of Robotic Versus Laparoscopic Hysterectomy for Endometrial Cancer

J Clin Oncol 30 (2012) Online first, 30. 1. 2012
2011

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

J Clin Oncol 29 (2011) 3278-3285

A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer

A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer. Gyn Oncol 121 (2011) 112-117

A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study

Gyn Oncol 121 (2011) 118-121

Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: A randomised trial

Gyn Oncol 121 (2011) 76-82

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Ann Oncol 22 (2011) 636-642

Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?

Gyn Oncol 120 (2011) 189-192

Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study

Gyn Oncol 120 (2011) 185-188

Conservative treatment of early endometrial cancer: Preliminary results of a pilot study

Gyn Oncol 120 (2011) 43-46

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

Cancer 116 (2010) 5415-5419
2010

Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184

Gyn Oncol 119 (2010) 538-542

Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma. Results of a prospective phase 2 trial

Cancer 116 (2010) 4973-4979

A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients

Cancer 116 (2010) 4735-4743

Long-Term Survival in Patients With Para-Aortic Lymph Node Metastasis With Systematic Retroperitoneal Lymphadenectomy Followed by Adjuvant Chemotherapy in Endometrial Carcinoma

Int J Gyn Cancer 20 (2010) 1000-1005

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

Lancet 375 (2010) 1156-1172

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

Lancet 375 (2010) 816-823

Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: A clinical experience

Lung Cancer 67 (2010) 408-412

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Gyn Oncol 116 (2010) 15-20